Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevalu
about
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014Short-term consequences of angiographically-confirmed coronary stent thrombosisThe impact of renal impairment on long-term safety and effectiveness of drug-eluting stentsAssociation of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosisAngiographically confirmed stent thrombosis in contemporary practice: insights from intravascular ultrasound.Long-term Outcomes of Primary Percutaneous Coronary Intervention with Second-generation Drug-eluting Stents in ST-elevation Myocardial Infarction Patients Caused by Very Late Stent ThrombosisUremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.Thrombosis in the uremic milieu--emerging role of "thrombolome".High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention.The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia.Mechanisms of stent thrombosis: insights from optical coherence tomographyLocal sustained delivery of acetylsalicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded artery.Very Late Stent Thrombosis of Sirolimus-eluting Stent 59 Months After Implantation: A First Report from The Middle-East and Review of Literature.Stent thrombosis: an overview.Stent thrombosis in patients with chronic kidney disease.Late stent thrombosis: the last remaining obstacle in coronary interventional therapy.Therapy in ST-elevation myocardial infarction: reperfusion strategies, pharmacology and stent selection.Prevention of stent thrombosis: challenges and solutions.Causes, assessment, and treatment of stent thrombosis--intravascular imaging insights.Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort).Very long-term clinical and angiographic outcomes after sirolimus- and paclitaxel-eluting stent placement for ST-elevation myocardial infarction: a propensity score-matched comparison.Angioscopic findings before and after thrombus-related drug-eluting stent failure.Platelet Function Testing-Guided Antiplatelet TherapyDrug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients.Deterioration of renal function at stent implantation can predict long-term outcome after stent thrombosis.Stent thrombosis: incidence, predictors and new technologiesThe different features of angiographic peri-stent contrast staining after implantation of sirolimus-eluting stents.Predictors of Impaired Reperfusion after Percutaneous Coronary Intervention in Patients with In-Hospital Acute Stent Thrombosis: A Retrospective Analyses of 5 Years of Data.Coronary stenting: A matter of revascularization.Early stent thrombosis. Aetiology, treatment, and prognosis.Procedural success and long-term outcomes of aspiration thrombectomy for the treatment of stent thrombosis.Contemporary clinical characteristics, treatment, and outcomes of angiographically confirmed coronary stent thrombosis: results from a multicenter California registry.Angiographic characteristics of definite stent thrombosis: role of thrombus grade, collaterals, epicardial coronary flow, and myocardial perfusion.Provisional side-branch stenting in distal left main lesions: one-size-may-not-fit-all.Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans.Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up.Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.Timing and long-term prognosis of recurrent MI after primary angioplasty : Stent thrombosis vs. non-stent-related reinfarction.Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study.Midterm outcomes of bare-metal stenting after primary stenting for ST-segment elevated myocardial infarctions in the drug-eluting stent era: a propensity score-matched comparison with sirolimus-eluting stent.
P2860
Q26785321-C38389B5-4F50-4D10-9BA1-E28F78065AA6Q28534401-95C7FE27-3CEB-41C7-9FB0-C94259AB96EAQ28542739-E3C18AA1-6A74-4FA3-AC09-DF5B95F87298Q28545192-5F7A8252-F5C1-4CEA-A006-11D97487EA80Q30415522-BB3D64E3-8EFB-4A9C-8FC7-246825BA374BQ33609009-37E4832B-0251-4971-BBBE-EE1318FE0680Q35532690-8FCD5F8E-940E-4ACF-99D4-22BCFCAA606FQ35532702-1337906B-291E-4480-9934-708D5F0B4EDBQ36205878-BD816F96-97A4-4175-B8C4-55B6FEB86A94Q36417926-B952DA35-207B-4FFE-A115-6D15C971914DQ36949011-117263F2-E1AA-46FC-99DE-2813BB254444Q37464405-67696950-C643-4AC8-A9F9-EB4E900AA289Q37897983-44678412-580E-48BF-AFC8-9D9F097AAAB9Q38014978-EE095194-C476-436C-A046-79616CA016A6Q38014979-61C120FA-7CE6-4D06-9F10-E9118F80CD30Q38023285-09B35B49-6ACF-415E-9FD9-200100B6A44AQ38199360-CF8C894A-17E6-415B-BD96-7B115CC2C4B5Q38346245-53EC1FA4-5E29-4F77-8239-FA874FC6E5F4Q38381419-35F241AD-6CA9-4FA6-B936-C6CB302CC872Q38673193-AFB9C9E1-3FDB-4DA4-8137-A50588B8FC4BQ38894880-981FC953-DC64-4D88-9CF0-899C13B6BCE1Q39041513-14011900-561B-4012-950E-938403E1E99BQ39341052-69E0D26A-EFB9-46B0-8AA9-A0E513181BEEQ39495930-0F2EEC58-29A9-4855-86F9-EDD5A3FB7F63Q40532536-DE01AB79-AB36-4547-A9AA-3926015BCA60Q41962888-38E7B988-3858-441D-90AB-023B2E51F231Q42319183-183B41AA-9AC4-49D1-A48F-8F810D226889Q42339380-7028DDB1-1EF1-43F7-B88B-FD4AA0BBB6E9Q42371965-3919CC0D-2D90-4E3C-8928-1E660D0BE6C7Q43051128-E07E67A3-6785-4883-ABC4-A964C1716840Q44638170-481D68EE-2A57-45C7-A74A-73CC5BC18278Q45102814-AE79E6DB-71CC-4E94-936C-CA18506D82A0Q46431709-49F87D21-ACF0-4405-B895-05CB0FA61B30Q47379473-E441F425-B41E-4FFB-8ACD-17324519D635Q48224247-02C3FD74-1BB6-4DA3-AED7-C82E693E72F5Q48246511-D4D9C560-C451-43B6-AB0E-AF1A089811E0Q48290973-67EE9D00-0E5A-40AC-B871-288D5E5C371CQ51273826-6BEF615F-749A-44F3-A439-34050B68DC91Q51545745-BB6C25B1-66A8-43B4-A4A2-2F86C3C997B3Q51682183-4E503471-2E04-4D3A-881C-EDEFA809F2EF
P2860
Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevalu
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparisons of baseline demogr ...... ombosis for Review and Reevalu
@en
Comparisons of baseline demogr ...... ombosis for Review and Reevalu
@nl
type
label
Comparisons of baseline demogr ...... ombosis for Review and Reevalu
@en
Comparisons of baseline demogr ...... ombosis for Review and Reevalu
@nl
prefLabel
Comparisons of baseline demogr ...... ombosis for Review and Reevalu
@en
Comparisons of baseline demogr ...... ombosis for Review and Reevalu
@nl
P2093
P921
P1433
P1476
Comparisons of baseline demogr ...... iew and Reevaluation (RESTART)
@en
P2093
Eizo Nishimura
Emi Hiyoshi
Kazuaki Mitsudo
Ken Kozuma
RESTART Investigators
Shunichi Miyazaki
Tadanori Aizawa
Takaaki Isshiki
Takeshi Kimura
Takeshi Morimoto
P356
10.1161/CIRCULATIONAHA.109.903955
P407
P577
2010-06-21T00:00:00Z